Sentien Biotechnologies, Inc.
MEDFORD, MA · CIK 0001650699 · Medtech · Private
Extracorporeal bioreactor system that delivers mesenchymal stem cell secretions to treat acute myocardial infarction
- Grants
- $4.6M
- 5 awards
- Sector median: 1
- Raised
- $1.0M
- 1 Form D · Aug 2015
- 134 months since last filing
- Contracts
- $610K
- 2 awards · Defense, Health and Human S
- #368 of 4531 in medtech
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201120132015201720192021
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Defense · SBIR Phase I Army 2011.2 Log #11256002 | $99,974 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · Stem Cell Bioreactor for Cardiac Care | $240,729 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase II · Transforming Dialysis into a Controlled Drug Delivery System for Stem Cell Derive | $1,006,437 | |
| Private capital raised | Form D · SEC | $1,049,999 | |
| Federal grant | Department of Health and Human Services · Phase II · Stem Cell Bioreactor for Cardiac Care | $1,571,857 | |
| Federal grant | Department of Health and Human Services · Phase II · Transforming Dialysis into a Controlled Drug Delivery System for Stem Cell Derive | $962,626 | |
| Federal grant | Department of Health and Human Services · Phase II · Stem Cell Bioreactor for Cardiac Care | $800,030 | |
| Federal contract | Department of Health and Human Services · Sentien Biotechnologies, Inc.: R&d Of Ex Vivo Cell Therapy | $510,265 |
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 365 | Starr Life Sciences Corp. | $642K | $4.1M |
| 366 | Beacon Biosignals | $641K | $133M |
| 367 | Medigus | $623K | $8.6M |
| 368 | Sentien Biotechnologies, Inc. | $610K | $1.0M |
| 369 | PGXL TECHNOLOGIES LLC | $606K | — |
| 370 | Ribomed Biotechnologies, Inc. | $603K | — |
| 371 | SONATA SCIENTIFIC LLC | $600K | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Greg BaileyDirector
- Rich GanzDirector
- Martin HeideckerDirector
- Brian MillerDirector · Executive Officer
- Biju ParekkadanDirector
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.